Here we have combined macromolecular crowding with the pro-fibrotic and pleiotropic cytokine TGF-β1 known to be elevated in IPF [9], to develop a robust, high content, phenotypic screening assay using patient-derived pulmonary fibroblasts. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.